Genetic Signatures

37 Consolidated Statement of Financial Position CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2021 18 Consolidated Note 2021 $’000s 2020 $’000s Assets Current Assets Cash and cash equivalents 7 30,121 31,176 Trade and other receivables 8 5,373 5,223 Inventory 9 12,134 7,252 Government grant receivable 10 - 2,554 Total Current Assets 47,628 46,205 Non-Current Assets Property, plant and equipment 11 5,659 2,675 Intangible assets 371 101 Right of use assets - leases 12 389 734 Total Non-Current Assets 6,419 3,510 Total Assets 54,047 49,715 Liabilities Current Liabilities Trade and other payables 13 3,352 2,368 Lease liabilities 12 334 313 Provisions 14 938 657 Total Current Liabilities 4,624 3,338 Non-Current Liabilities Lease liabilities 12 65 428 Provisions 14 18 20 Total Non-Current Liabilities 83 448 Total Liabilities 4,707 3,786 Net Assets 49,340 45,929 Equity Issued capital 15 84,164 84,013 Reserves 16 3,334 1,830 Accumulated losses (38,158) (39,914) Total Equity 49,340 45,929 The above Consolidated statement of financial position should be read in conjunction with the accompanying notes